ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OMED Oncomed Pharmaceuticals, Inc.

0.89
0.00 (0.00%)
Pre Market
Last Updated: 20:00:00
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 0.9175
Ask Price 0.89
News -
Company Name Stock Ticker Symbol Market Type
Oncomed Pharmaceuticals, Inc. OMED NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.89 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.89
Trades Volume Avg Volume
0 0 -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.89 USD

Oncomed Pharmaceuticals, Inc. Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 34.43M - - - -9.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

ONCOMED PHARMACEUTICALS INC News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No OMED Message Board. Create One! See More Posts on OMED Message Board See More Message Board Posts

Historical OMED Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

ONCOMED PHARMACEUTICALS INC Description

OncoMed Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapeutics that address the fundamental biology driving cancer's growth, resistance, recurrence, and metastasis. The company's therapeutic candidates and preclinical programs include Navicixizumab, Anti-TIGIT, GITRL-Fc, and Rosmantuzumab.

Your Recent History

Delayed Upgrade Clock